3001: Anaphylaxis in Infants
Infants present unique challenges in the recognition and treatment of anaphylaxis. This seminar will allow for discussion of these issues, including the opportunity for participants to address their questions to experts on this topic.
Credit claiming for this activity will be available through December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee.
- Nurse Practitioners
- Allied Health Professionals
Upon completion of this activity, participants should be able to:
- Describe the unique aspects and challenges in the recognition and management of anaphylaxis in infants
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to1.00 Contact Hours.
CREDIT CLAIMING PERIOD
Credit claiming for this activity will expire at 11:59 pm on December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee.
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at firstname.lastname@example.org
Activity-related questions should be directed to email@example.com.
- 1.00 AttendanceAttendance credit.
- 1.00 CECE credit.
- 1.00 CMECME credit.
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.
Internet Explorer is no longer supported.